Antimycobacterial and antimicrobial study of new 1,2,4-triazoles with benzothiazoles

Archiv der Pharmazie

Volumn 343, Issue 11-12, 2010, Pages 692-699

  Patel, Navin B ^a   Khan, Imran H ^a   Rajani, Smita D ^b  

^a VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

^b Microcare Laboratory   (India)

Author keywords

1,2,4 Triazole; Antimicrobial activity; Antimycobacterial activity

Indexed keywords

2 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 1,3,4 OXADIAZOLE; 2 HYDRAZINO (5,6 DICHLORO) 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 4 CHLORO 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 4 METHYL 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 4 NITRO 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 6 BROMO 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 6 CHLORO 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 6 FLUORO 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 6 METHOXY 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 6 METHYL 1,3 BENZOTHIAZOLE; 2 HYDRAZINO 6 NITRO 1,3 BENZOTHIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N (5,6 DICHLORO) 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 4 CHLORO 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 4 METHYL 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 4 NITRO 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 6 BROMO 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 6 CHLORO 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 6 FLUORO 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 6 METHOXY 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 6 METHYL 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; 3 (3 PYRIDYL) 5 (4 METHOXYPHENYL) 4 (N 6 NITRO 1,3 BENZOTHIAZOL 2 AMINO) 4H 1,2,4 TRIAZOLE; ANTIMYCOBACTERIAL AGENT; BENZOTHIAZOLE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS CLAVATUS; ASPERGILLUS NIGER; BACTERIAL STRAIN; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; INFRARED RADIATION; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; BENZOTHIAZOLES; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SPECTRUM ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78649886754     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000061     Document Type: Article

References (32)

1. B. R. Bloom, C. J. L. Murray, Science 1992, 257, 1055-1064.
2. P. F. Barnes, A. B. Blotch, P. T. Davidson, D. E. Snider, N. Engl. J. Med. 1991, 324, 1644-1650.
3. P. I. Fujiwara, S. V. Cook, C. M. Rutherford, J. T. Crawford, S. E. Glickman, B. N. Kreiswirth, P. S. Sachdev, S. S. Osahan, A. Ebrahimzadeh, T. R. Frieden, Arch. Intern. Med. 1997, 157, 531-536.
4. Y. L. Janin, Bioorg. Med. Chem. 2007, 15, 2479-2513.
5. E. E. Telzak, K. Sepkowitz, P. Alpert, S. Mannheimer, F. Mederd, W. El-Sadr, S. Blum, A. Gagliardi, N. Salomon, G. Turett, N. Engl. J. Med. 1995, 333, 907-911.
6. I. Bastian, R. Colebuuders, Drugs 1999, 58, 633-661.
7. K. Babaoglu, M. A. Page, V. C. Jones, M. R. McNeil, C. Dong, J. H. Naismith, R. E. Lee, Bioorg. Med. Chem. Lett. 2003, 13, 3227-3230.
8. M. R. Shiradkar, S. Gorentia Venkata, V. Dasari, S. Tatikonda, K. C. Akula, R. Shah, Eur. J. Med. Chem. 2007, 42, 807-816.
9. K. Dabak, O. Serez, A. Akar, O. Anac, Eur. J. Med. Chem. 2003, 38, 215-218.
10. S. D. Joshi, H. M. Vagdevi, V. P. Vaidya, G. S. Gadaginamath, Eur. J. Med. Chem. 2008, 43, 1989-1996.
11. D. Zampieri, M. G. Mamolo, E. Laurini, M. Fermeglia, P. Posocco, S. Pricl, E. Banfi, G. Scialino, L. Vio, Bioorg. Med. Chem. 2009, 17, 4693-4707.
12. N. Ulusoy, A. Gursoy, G. Otuk, IL Farmaco 2001, 56, 947-952.
13. A. Ozdemir, G. Turun-Zitouni, Z. A. Kaplancikli, P. Chevallet, J. Enzyme Inhib. Med. Chem. 2007, 22, 511-516.
14. Y. A. Al-Soud, M. N. Al-Dweri, N. A. Al-Masoudi, IL Farmaco 2004, 59, 775-783.
15. Z. Wang, B. Wu, K. L. Kuhen, B. Bursulaya, T. N. Nguyen, D. G. Nguyen, Y. He, Bioorg. Med. Chem. 2006, 16, 4174-4177.
16. S. Papakonstantinou-Garoufalias, N. Pouli, P. Marakos, A. Chytyroglou-Ladas, IL Farmaco 2002, 57, 973-977.
17. L. Labanauskasa, E. Udrenaite, P. Gaidelis, A. Brukštus, IL Farmaco 2004, 59, 255-259.
18. S. A. Khanum, S. Shashikant, S. Umesha, R. Kavita, Eur. J. Med. Chem. 2005, 40, 1156-1162.
19. P. Vicini, A. Geronikaki, M. Incerti, B. Busonera, G. Poni, C. A. Cabras, P. La Colla, Bioorg. Med. Chem. 2003, 11, 4785-4789.
20. J. Koci, V. Klimesova, K. Waisser, J. Kaustova, H. M. Dahse, U. Mollmann, Bioorg. Med. Chem. Lett. 2002, 12, 3275-3279.
21. K. S. Lin, M. L. Debnath, C. A. Mathis, W. Klunk, Bioorg. Med. Chem. Lett. 2009, 19, 2258-2262.
22. K. Serdons, T. Verduyckt, D. Vanderghinste, P. Borghgraef, J. Cleynhens, F. Van Leuven, H. Kung, G. Bormans, A. Verbruggen, Eur. J. Med. Chem. 2009, 44, 1415-1426.
23. G. Turan-Zitouni, S. Demirayak, A. Ozdemir, Z. A. Kaplancikli, M. T. Yildiz, Eur. J. Med. Chem. 2003, 39, 267-272.
24. S. T. Huang, I. J. Hsei, C. Chen, Bioorg. Med. Chem. 2006, 14, 6106-6119.
25. C. J. Lion, C. S. Matthews, G. Wells, T. D. Bradshaw, M. F. G. Stevens, A. D. Westwell, Bioorg. Med. Chem. Lett. 2006, 16, 5005-5008.
26. N. Siddiqui, S. N. Pandeya, S. A. Khau, J. Stables, A. Rana, M. Alam, Md. F. Arshad, M. A. Bhat, Bioorg. Med. Chem. 2007, 17, 255-259.
27. C. J. Barnett, U. S. Patent 3,937,714.
28. V. Kumar, R. K. Roy, V. Kumar, A. Kukshal, V. P. Yadav, J. Indian Chem. Soc. 2008, 85, 333-335.
29. A. Rattan, Antimicrobials in laboratory medicine, B. I. Churchill, Livingstone, New Delhi 2000, pp. 85-110.
30. P. Anargyros, S. J. A. David, S. L. L. Irene, J. Clin. Microbiol. 1990, 28, 1288-1291.
31. R. R. Shah, R. D. Mehta, A. R. Parikh, J. Indian Chem. Soc. 1985, 62, 255-257.
32. N. C. Desai, H. K. Shukla, K. A. Tahker, J. Indian Chem. Soc. 1984, 61, 239-240.